Banking matchmakers busy

Article Abstract:

J.P. Morgan & Co., the fourth-largest banking firm in the US, is reportedly the takeover target of Germany's biggest bank, Deutsche Bank AG. The speculations came about as a result of an article in "Business Week" that reported that a European bank had met with J.P. Morgan to buy the bank for $175 per share, but that J.P. Morgan was asking for $200 a share. J.P. Morgan, which has long been rumored to be a takeover target, would give a European bank a solid global brand name, merger and acquisition businesses, an asset management unit and a covetable customer base.

Comment:

Is reportedly eyeing J P Morgan and Co as a takeover target

United States, Deutsche Bank AG, J.P. Morgan and Company Inc., Article

---

EC hopes GE flap won't spoil relations

Article Abstract:

European Commission's (EC) chief Mario Monti said on Jun 26, 2001 that the agency's decision to disapproved the planned $41-billion merger of General Electric Co (GE) and Honeywell Inc should not signal a breach of US- European relations in the area of antitrust law. Responding to US criticism on the decision, Monti predicted increased cooperation between the EC and US antitrust officials. Pres George W. Bush and his top economic aides have condemned EC for rejecting the GE-Honeywell agreement, which was approved by US regulators.

Government regulation (cont), European Union, Merger Regulation, Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Acquisitions and mergers, Corporation law

---

Deutsche, Dresdner banks join forces

Article Abstract:

Deutsche Bank, the leading bank in Germany, announced in Mar 9, 2000 that it is acquiring Dresdner Bank, the third largest bank in the country. The transaction, which is worth $29.5 billion, would increase Deutsche Bank's assets to $1.2 trillion. Under the terms of the deal, Deutsche Bank stockholders will control about two-thirds of the combined company, which will retain the Deutsche Bank name.

Dresdner Bank

Similar abstracts:

• Abstracts: Generics win major court case. Generics lash out at health regulations. Court stays prohibition of generic AZT sales
• Abstracts: Second Cup stirring up business. Laidlaw expects sale to net $2-billion
• Abstracts: Evading the issue. Homes win out. Trusts in a twist
• Abstracts: Pie in the sky. Ski slopes get a lift. Charge of the flight brigade
• Abstracts: CIBC reviews insurance business. Kingsway plans to slow acquisition strategy. Boliden pushed deep into red

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.